Story thread · 3 reports / 3 sources
Is Paxlovid Any Better Than Placebo for Long COVID?
medpagetoday.com · 11d
How the coverage leans
Across 3 sources · syndicated copies counted once
(MedPage Today) -- Nirmatrelvir-ritonavir (Paxlovid) wasn't any more effective at relieving long COVID symptoms than placebo, according to a large double-blind phase II trial. At 90 days in RECOVER-VITAL, symptoms meaningfully improved among the...
First report: Paxlovid did not help long Covid, study finds — statnews.com, 13d
The coverage
- Most Children Rebounded After COVID-19 Disruptions, Study Finds
news.utexas.edu · 12d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.